Market Overview

UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook

Share:
Related JNJ
Baird Says Buy Cooper Companies At Current Levels
Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet Regimen Odefsey
Hundred Thousand Dollars Of Income Portfolio - June Update (Seeking Alpha)

Johnson & Johnson (NYSE: JNJ) reported a rise in its second-quarter earnings and lifted its profit forecast for the full year.

The New Brunswick, New Jersey-based company posted a quarterly profit of $4.3 billion, or $1.51 per share, compared to $3.8 billion, or $1.33 per share, in the year-ago period. Excluding certain items, Johnson & Johnson's adjusted earnings came in at $1.66 per share.

Its revenue climbed 9.1% to $19.5 billion. However, analysts were expecting earnings of $1.55 per share on revenue of $19 billion.

For the full-year, Johnson & Johnson's raised its adjusted earnings outlook to $5.85 to $5.92 per share from its earlier forecast of $5.80 to $5.90 per share.

Worldwide consumer sales rose 2.4% y/y to $3.7 billion in the quarter, while worldwide pharmaceutical sales climbed 21.1% to $8.5 billion.

Worldwide medical devices and diagnostics sales increased 0.7% to $7.2 billion in the quarter. Johnson & Johnson's world-wide Olysio sales surged to $831 million in the quarter, up from $354 million in the first quarter.

Alex Gorsky, Chairman and Chief Executive Officer said, "Our strong second-quarter results reflect the continued success of our new product launches and the progress we have made in achieving our near-term priorities."

Johnson & Johnson shares gained 0.11% to $105.50 in pre-market trading.

Posted-In: profitEarnings News

 

Related Articles (JNJ)

View Comments and Join the Discussion!